|
2025
|
G/S
|
Downloadable software in the nature of a mobile application for providing healthcare-related info... |
|
|
G/S
|
Medical information services, namely providing information related to healthcare and diseases and... |
|
|
G/S
|
Promoting public awareness for Obstructive Sleep Apnea |
|
|
G/S
|
Medical information services in the field of obesity; medical information services. |
|
|
G/S
|
Medical and scientific research in the field of breast cancer |
|
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Providing a website featuring information in the fields of product data and product ordering, nam... |
|
|
G/S
|
Platform as a service featuring a clinical site portal for accessing clinical trial applications.... |
|
|
G/S
|
Electronic psychological assessment tool consisting primarily of computer software and downloadab... |
|
|
G/S
|
Medical information services in the field of inflammatory bowel disease and autoimmune diseases a... |
|
|
G/S
|
Medical and scientific research in the field of Alzheimer’s Disease |
|
|
G/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, A... |
|
|
G/S
|
Promoting public awareness of obstructive sleep apnea Medical information services in the field o... |
|
|
G/S
|
Promoting public awareness of diabetes Medical information services in the field of diabetes |
|
|
G/S
|
Medical information services in the fields of diabetes, weight loss, sleep apnea, cardiovascular ... |
|
|
G/S
|
Software for use in providing educational content and training in the field of gastroenterology; ... |
|
|
G/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention an... |
|
|
G/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of obstructive... |
|
|
G/S
|
Product development; Pharmaceutical products development; Biological development services; Resear... |
|
|
G/S
|
Medical and scientific research in the field of solid tumors |
|
|
G/S
|
Venture capital financing; venture capital services, namely, providing financing to seed and earl... |
|
|
G/S
|
Scientific laboratory services, namely, providing shared wet laboratory facilities and shared lab... |
|
|
G/S
|
Retail pharmacy services; online retail pharmacy services; mail order pharmacy services; online r... |
|
2024
|
Invention
|
Tubing having visual markers for visualization of media therein.
A transparent tubing is provide... |
|
|
G/S
|
Patient services programs and related programs and activities relating to Alzheimer patients and ... |
|
|
Invention
|
Fgfr3 inhibitor compounds.
The present invention provides compounds of the formula:
The presen... |
|
|
G/S
|
Medical information services in the field of atopic dermatitis. |
|
|
G/S
|
Medical information services |
|
|
G/S
|
Medical information services in the field of atopic dermatitis |
|
|
Invention
|
Techniques for processing wirelessly broadcast packets from a medical device with dose-related da... |
|
|
G/S
|
Medical and scientific research in the field of cardiovascular diseases and disorders |
|
|
Invention
|
Devices and methods for drug delivery. A drug delivery device includes a mechanical drive assembl... |
|
|
Invention
|
Novel methods for the preparation of 3-azabicylco[3.1,0]hexane-6-carboxamide derivatives. Methods... |
|
|
Invention
|
Ahr agonists. The present disclosure relates to certain AHR agonist compounds, for example, havin... |
|
|
Invention
|
Nanoparticles and formulations thereof for delivering therapeutic agents throughout the central n... |
|
|
Invention
|
Humanized anti-s100a9 antibody. It is provided a humanized isolated antibody or functional fragme... |
|
|
Invention
|
Transferrin receptor binding proteins and uses thereof. e.g.e.g.e.g., neurodegenerative disease) ... |
|
|
Invention
|
Insulin-fc fusion proteins. The present invention relates to fusion proteins comprising an insuli... |
|
|
Invention
|
Processes for the preparation of substituted phenylacetonitriles and substituted phenylacetic aci... |
|
|
Invention
|
Process for making a kras g12c inhibitor. The present disclosure provides processes that can be u... |
|
|
G/S
|
Educational services, namely, programs for healthcare personnel about clinical cases and communic... |
|
|
G/S
|
Medical information services, namely providing information related to Alzheimer's disease |
|
|
Invention
|
Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload. The present ... |
|
|
G/S
|
Custom manufacturing of pharmaceuticals and clinical trial materials Pharmaceutical products deve... |
|
|
Invention
|
Ppp1r15b rna interference agents. Provided herein are PPP1R15B RNAi agents and compositions compr... |
|
|
Invention
|
Kras inhibitors. 1244 are as described herein, pharmaceutically acceptable salts thereof, and met... |
|
|
Invention
|
Kras inhibitors.
The present invention provides compounds of the formula:
The present inventio... |
|
|
Invention
|
Fluidized bed granulation and coating systems and methods.
A fluidized bed granulation (FBG) sys... |
|
|
Invention
|
Incretin analogs and uses thereof.
Incretin analogs are provided that have activity at each of t... |
|
|
Invention
|
Self-healing hydrogel. A self-healing hydrogel which includes a network of poly(3,4- ethylenediox... |
|
|
Invention
|
Downtime prediction for management of machines in manufacturing network. A method of managing a m... |
|
|
Invention
|
Neuregulin-4 compounds and methods of use.
The present invention relates to neuregulin (NRG) 4 c... |
|
|
Invention
|
Pde1 inhibitors. The present invention provides a compound of Formula (I), wherein R1, R2, R3, R4... |
|
|
Invention
|
Methods and systems for managing diabetes. This disclosure relates generally to systems, methods ... |
|
|
Invention
|
Therapeutic agent delivery device with controls. A therapeutic agent delivery device includes a r... |
|
|
Invention
|
At2r antagonists and uses thereof.
This invention provides certain piperidine compounds as AT2R ... |
|
|
Invention
|
Strain gauge sensor. The present disclosure is directed at a strain gauge sensor, and in particul... |
|
|
Invention
|
Speed of movement system and method. A system is provided for providing real-time feedback to an ... |
|
|
Invention
|
(s)-3-((6-fluoropyridin-3-yl)methyl)-1-(5-(pyridin-4-yl)-4h-1,2,4-triazol-3-yl)piperidin-2-one be... |
|
|
Invention
|
Amyloid precursor protein (app) rnai agents.
Provided herein are APP RNAi agents and composition... |
|
|
Invention
|
Pd-1 agonist antibodies and methods of treating autoimmune diseases with a pd-1 agonist antibody.... |
|
|
Invention
|
Amyloid precursor protein (app) rnai agents. Provided herein are APP RNAi agents and compositions... |
|
|
Invention
|
Engineered transferrin receptor binding peptides as well as methods of making and using the same.... |
|
|
Invention
|
Process for preparing a gip/glp1 dual agonist.
The present invention provides novel intermediate... |
|
|
Invention
|
Anomaly detection in manufacturing network. A method for detecting anomalies using alarm data fro... |
|
|
Invention
|
Compounds and methods targeting epiregulin.
The present invention relates to epiregulin antibodi... |
|
2023
|
Invention
|
Drug delivery device |
|
|
Invention
|
Display screen with a graphical user interface |
|
|
Invention
|
Systems and methods for internal drug loading for infusion processes.
Methods for applying a the... |
|
|
Invention
|
Solid phase peptide synthesis wash process.
A method is disclosed for washing an amino acid that... |
|
|
Invention
|
Methods and systems for detecting events using actigraphy data.
A computerized method is provide... |
|
|
Invention
|
Regional tau imaging for diagnosing and treating alzheimer's disease.
Disclosed are methods for ... |
|
2022
|
Invention
|
Dosing regimens for selective treg stimulator rur20kd-il-2 and related compositions.
The instant... |
|
|
Invention
|
Display screen with animated graphical user interface |
|
|
Invention
|
Antibody optimization.
The present disclosure relates to methods of developing, designing, and p... |
|
|
Invention
|
Label |
|
|
Invention
|
Box |
|
2021
|
Invention
|
Gip/glp1 co-agonist compounds. The present invention relates to compounds having activity at both... |
